These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27003398)

  • 1. The TGF-β Signalling Network in Muscle Development, Adaptation and Disease.
    Chen JL; Colgan TD; Walton KL; Gregorevic P; Harrison CA
    Adv Exp Med Biol; 2016; 900():97-131. PubMed ID: 27003398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia.
    Lan XQ; Deng CJ; Wang QQ; Zhao LM; Jiao BW; Xiang Y
    Gen Comp Endocrinol; 2024 Jul; 353():114513. PubMed ID: 38604437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
    Tsuchida K; Nakatani M; Uezumi A; Murakami T; Cui X
    Endocr J; 2008 Mar; 55(1):11-21. PubMed ID: 17878607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta and myostatin signaling in skeletal muscle.
    Kollias HD; McDermott JC
    J Appl Physiol (1985); 2008 Mar; 104(3):579-87. PubMed ID: 18032576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
    Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease.
    Chen JL; Walton KL; Hagg A; Colgan TD; Johnson K; Qian H; Gregorevic P; Harrison CA
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5266-E5275. PubMed ID: 28607086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of myostatin and bone morphogenetic proteins in muscular disorders.
    Tsuchida K
    Expert Opin Biol Ther; 2006 Feb; 6(2):147-54. PubMed ID: 16436040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting.
    Zhang P; He J; Wang F; Gong J; Wang L; Wu Q; Li W; Liu H; Wang J; Zhang K; Li M; Huang X; Pu C; Li Y; Jiang F; Wang F; Min J; Chen X
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):557-573. PubMed ID: 30884219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible role of myostatin in skeletal muscle atrophy and cachexia.
    Jespersen J; Kjaer M; Schjerling P
    Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A.
    Lee SJ; Lehar A; Liu Y; Ly CH; Pham QM; Michaud M; Rydzik R; Youngstrom DW; Shen MM; Kaartinen V; Germain-Lee EL; Rando TA
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):30907-30917. PubMed ID: 33219121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activins, myostatin and related TGF-beta family members as novel therapeutic targets for endocrine, metabolic and immune disorders.
    Tsuchida K
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):157-66. PubMed ID: 15180456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration.
    Pasteuning-Vuhman S; Boertje-van der Meulen JW; van Putten M; Overzier M; Ten Dijke P; Kiełbasa SM; Arindrarto W; Wolterbeek R; Lezhnina KV; Ozerov IV; Aliper AM; Hoogaars WM; Aartsma-Rus A; Loomans CJ
    FASEB J; 2017 Jan; 31(1):238-255. PubMed ID: 27733450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic disruption of Smad7 impairs skeletal muscle growth and regeneration.
    Cohen TV; Kollias HD; Liu N; Ward CW; Wagner KR
    J Physiol; 2015 Jun; 593(11):2479-97. PubMed ID: 25854148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis.
    Matsakas A; Diel P
    Int J Sports Med; 2005 Mar; 26(2):83-9. PubMed ID: 15726494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myostatin in muscle growth and repair.
    Sharma M; Langley B; Bass J; Kambadur R
    Exerc Sport Sci Rev; 2001 Oct; 29(4):155-8. PubMed ID: 11688787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The function of Myostatin and strategies of Myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle.
    Patel K; Amthor H
    Neuromuscul Disord; 2005 Feb; 15(2):117-26. PubMed ID: 15694133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel role for ß-adrenergic signalling in skeletal muscle growth, development and regeneration.
    Ryall JG; Church JE; Lynch GS
    Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):397-401. PubMed ID: 19793099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myostatin: Basic biology to clinical application.
    Esposito P; Picciotto D; Battaglia Y; Costigliolo F; Viazzi F; Verzola D
    Adv Clin Chem; 2022; 106():181-234. PubMed ID: 35152972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myostatin - a modern understanding of the physiological role and significance in the development of age-associated diseases.].
    Gazdanova AA; Kukes VG; Parfenova OK; Sidorov NG; Perkov AV; Solovieva SA; Ryazantceva OV; Lenkova NI
    Adv Gerontol; 2021; 34(5):701-706. PubMed ID: 34998007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TGF-β signaling in inherited and acquired myopathies.
    Burks TN; Cohn RD
    Skelet Muscle; 2011 May; 1(1):19. PubMed ID: 21798096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.